Page 20 - Cell Host News Today

Lab-made therapies are rapidly losing their healing power, forcing researchers around the world to devise new antibodies that are both more potent and more resistant to new variants.

"With new COVID variants and subvariants evolving faster and faster, each chipping away at the effectiveness of the leading vaccines, the hunt is on for a new kind of vaccine," reports the Daily Beast, "one that works equally well on current and future forms of the novel coronavirus. "Now research...

In a recent study published in the journal Cell Host & Microbe, researchers pursued novel approaches that could help find monoclonal antibodies (mAbs) broadly targeting coronaviruses (CoVs), especially genera beta CoVs.

A new study revealed that gut colonization by proteobacteria modulates cocaine neurobehavioral response in mice.

Bacteria in the small intestine adapt dynamically to our nutritional state, with individual species disappearing and reappearing.

Get latest articles and stories on Science at LatestLY. The diverse functions of immune cells in the body are extremely rigorously controlled in order to combat infections. How Toxoplasma infects so many people and animal species and spreads so quickly has long been a mystery to scientists. Science News | Researchers Reveal How Parasite Injects Protein into Nucleus of Immune Cell, Changes Cells Identity.

A new study has zoomed in to the cellular level of Toxoplasma gondii to investigate why the parasite can so successfully spread through the body.

On the first floor of Hitchner Hall, two rooms sit side by side, the air thick with an almost tropical humidity and quietly gurgling with the sound of circulating water. Inside, racks of tanks hold tens of thousands of tiny fish. They are all zebrafish — an inch-long relative of the minnow native to South […]

Two new subvariants of the Omicron strain of COVID-19 identified in recent months could fuel increased cases and hospitalizations in Canada through the fall and winter, infectious disease experts say.

A new study discusses how immune escape mutations allow a recent SARS-CoV-2 variant to evade neutralizing antibodies and cause breakthrough infections.